Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 37603 | 53 | 30.2 | 81% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 230 | 3 | P GLYCOPROTEIN//FMO3//TRIMETHYLAMINURIA | 49374 |
| 747 | 2 | P GLYCOPROTEIN//MULTIDRUG RESISTANCE//MDR1 | 12474 |
| 37603 | 1 | HLTH IMPROVING//BIOMED ENGN NANOSCI TRANSLAT NANOMED//CANCER CHERNOTHERAPY | 53 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | HLTH IMPROVING | address | 1152291 | 4% | 100% | 2 |
| 2 | BIOMED ENGN NANOSCI TRANSLAT NANOMED | address | 576146 | 2% | 100% | 1 |
| 3 | CANCER CHERNOTHERAPY | authKW | 576146 | 2% | 100% | 1 |
| 4 | CEBIOTEX BIOMED NANOFIBERS | address | 576146 | 2% | 100% | 1 |
| 5 | COMBINED INTERVENTIONAL THERAPY | authKW | 576146 | 2% | 100% | 1 |
| 6 | DRUG LOADED NANOFIBER MATS | authKW | 576146 | 2% | 100% | 1 |
| 7 | DRUG SENSITIVITY TEST IN VITRO | authKW | 576146 | 2% | 100% | 1 |
| 8 | GASTROESOPHAGEAL JUNCTION NEOPLASM | authKW | 576146 | 2% | 100% | 1 |
| 9 | GST PI INHIBITION ACTIVITY | authKW | 576146 | 2% | 100% | 1 |
| 10 | HOUSPITAL 4 | address | 576146 | 2% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Oncology | 335 | 42% | 0% | 22 |
| 2 | Materials Science, Biomaterials | 105 | 8% | 0% | 4 |
| 3 | Integrative & Complementary Medicine | 48 | 4% | 0% | 2 |
| 4 | Pharmacology & Pharmacy | 44 | 19% | 0% | 10 |
| 5 | Pathology | 32 | 8% | 0% | 4 |
| 6 | Gastroenterology & Hepatology | 27 | 8% | 0% | 4 |
| 7 | Medicine, Research & Experimental | 27 | 9% | 0% | 5 |
| 8 | Biophysics | 17 | 8% | 0% | 4 |
| 9 | Surgery | 10 | 9% | 0% | 5 |
| 10 | Engineering, Biomedical | 9 | 4% | 0% | 2 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | HLTH IMPROVING | 1152291 | 4% | 100% | 2 |
| 2 | BIOMED ENGN NANOSCI TRANSLAT NANOMED | 576146 | 2% | 100% | 1 |
| 3 | CEBIOTEX BIOMED NANOFIBERS | 576146 | 2% | 100% | 1 |
| 4 | HOUSPITAL 4 | 576146 | 2% | 100% | 1 |
| 5 | MINIST CHINESE PLA | 576146 | 2% | 100% | 1 |
| 6 | AFFILIATED HOSP TCM | 288072 | 2% | 50% | 1 |
| 7 | XJING HOSP | 288072 | 2% | 50% | 1 |
| 8 | ANHUI PROV CANC HOSP | 256062 | 4% | 22% | 2 |
| 9 | RICU | 192047 | 2% | 33% | 1 |
| 10 | INDEPENDENT MED BIOL UNIT | 96023 | 2% | 17% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | CELL BIOCHEMISTRY AND BIOPHYSICS | 4435 | 8% | 0% | 4 |
| 2 | CHINESE MEDICINE | 2729 | 2% | 0% | 1 |
| 3 | ONCOLOGY RESEARCH | 1920 | 4% | 0% | 2 |
| 4 | PARKINSONS DISEASE | 1380 | 2% | 0% | 1 |
| 5 | INTEGRATIVE CANCER THERAPIES | 1234 | 2% | 0% | 1 |
| 6 | NANOMATERIALS | 1193 | 2% | 0% | 1 |
| 7 | SAUDI JOURNAL OF BIOLOGICAL SCIENCES | 1085 | 2% | 0% | 1 |
| 8 | ASIAN PACIFIC JOURNAL OF CANCER PREVENTION | 922 | 6% | 0% | 3 |
| 9 | INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 917 | 6% | 0% | 3 |
| 10 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 704 | 6% | 0% | 3 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | YU, PF , DU, Y , YANG, LT , FAN, SF , WU, J , ZHENG, SS , (2014) SIGNIFICANCE OF MULTIDRUG RESISTANCE GENE-RELATED PROTEINS IN THE POSTOPERATIVE CHEMOTHERAPY OF GASTRIC CANCER.INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY. VOL. 7. ISSUE 11. P. 7945 -7950 | 8 | 42% | 2 |
| 2 | YU, PF , DU, Y , CHENG, XD , YU, QM , HUANG, L , DONG, RZ , (2014) EXPRESSION OF MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS AND THEIR RELATION TO POSTOPERATIVE INDIVIDUALIZED CHEMOTHERAPY IN GASTRIC CANCER.WORLD JOURNAL OF SURGICAL ONCOLOGY. VOL. 12. ISSUE . P. - | 6 | 35% | 4 |
| 3 | YU, PF , CHENG, XD , DU, Y , YANG, LT , HUANG, L , (2015) SIGNIFICANCE OF MDR-RELATED PROTEINS IN THE POSTOPERATIVE INDIVIDUALIZED CHEMOTHERAPY OF GASTRIC CANCER.JOURNAL OF CANCER RESEARCH AND THERAPEUTICS. VOL. 11. ISSUE 1. P. 46 -50 | 6 | 32% | 2 |
| 4 | WEN, CT , DUAN, QH , ZHANG, TY , LIU, YB , WU, Y , MA, KL , FAN, PS , JIA, WD , (2014) STUDIES ON ASSESSMENT METHODS OF MALIGNANT ASCITES RESIDUE AND CHANGES OF VERAPAMIL CONCENTRATION IN INTRAPERITONEAL PERFUSION CHEMOTHERAPY.CANCER CHEMOTHERAPY AND PHARMACOLOGY. VOL. 74. ISSUE 3. P. 473 -478 | 5 | 33% | 0 |
| 5 | MA, Y , WANG, X , ZONG, S , ZHANG, ZY , XIE, ZG , HUANG, YB , YUE, Y , LIU, S , JING, XB , (2015) LOCAL, COMBINATION CHEMOTHERAPY IN PREVENTION OF CERVICAL CANCER RECURRENCE AFTER SURGERY BY USING NANOFIBERS CO-LOADED WITH CISPLATIN AND CURCUMIN.RSC ADVANCES. VOL. 5. ISSUE 129. P. 106325 -106332 | 5 | 22% | 0 |
| 6 | ZHANG, ZY , LIU, S , QI, YX , ZHOU, DF , XIE, ZG , JING, XB , CHEN, XS , HUANG, YB , (2016) TIME-PROGRAMMED DCA AND OXALIPLATIN RELEASE BY MULTILAYERED NANOFIBER MATS IN PREVENTION OF LOCAL CANCER RECURRENCE FOLLOWING SURGERY.JOURNAL OF CONTROLLED RELEASE. VOL. 235. ISSUE . P. 125 -133 | 4 | 14% | 2 |
| 7 | HUANG, DX , LIN, C , WEN, XJ , GU, SY , ZHAO, P , (2016) A POTENTIAL NANOFIBER MEMBRANE DEVICE FOR FILLING SURGICAL RESIDUAL CAVITY TO PREVENT GLIOMA RECURRENCE AND IMPROVE LOCAL NEURAL TISSUE RECONSTRUCTION.PLOS ONE. VOL. 11. ISSUE 8. P. - | 3 | 18% | 0 |
| 8 | LI, Y , TAN, BB , ZHAO, Q , FAN, LQ , LIU, Y , HAO, YJ , ZHAO, XF , (2013) TUMOR CHEMOSENSITIVITY IS CORRELATED WITH EXPRESSION OF MULTIDRUG RESISTANCE ASSOCIATED FACTORS IN VARIOUSLY DIFFERENTIATED GASTRIC CARCINOMA TISSUES.HEPATO-GASTROENTEROLOGY. VOL. 60. ISSUE 121. P. 213-216 | 3 | 17% | 9 |
| 9 | FAN, PS , ZHANG, TY , HUANG, Q , WEI, Q , SUN, X , QIAN, LT , (2012) BASIC AND CLINICAL RESEARCH ON THE THERAPEUTIC EFFECT OF INTERVENTION IN PRIMARY LIVER CANCER BY TARGETED INTRA-ARTERIAL VERAPAMIL INFUSION.CELL BIOCHEMISTRY AND BIOPHYSICS. VOL. 62. ISSUE 1. P. 59-67 | 3 | 18% | 0 |
| 10 | QIAN, JQ , SUN, P , PAN, ZY , FANG, ZZ , (2015) ANNONACEOUS ACETOGENINS REVERSES DRUG RESISTANCE OF HUMAN HEPATOCELLULAR CARCINOMA BEL-7402/5-FU AND HEPG2/ADM CELL LINES.INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY. VOL. 8. ISSUE 9. P. 11934 -11944 | 2 | 22% | 1 |
Classes with closest relation at Level 1 |